Earningsreport

Q2/2024 3/31/2024 EPS -0.140 ZacksConsensus -0.140 ActVsEst 0.000 - In-Line

Cel-Sci Corporation  (CVM) 
NASDAQ:AMEX Investor Relations: cel-sci.com/investor_relations.html